All News
ACR20 - Day 3 Report
Here are my highlights from day three, Sunday, of the ACR 2020 Convergence.
Read Article
ACR20 - Day 4.1, 4.2 & 4.3
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Read Article
ACR20 - Day 3.3 & 3.4 Podcasts
Check out our many podcasts from the ACR 2020 meeting - listen in for faculty reports and overviews. You can also find the RheumNow podcast on Apple Podcast, Apple Car Play, Android Auto or where ever you prefer to listen.
Listen here:
Read Article
There is hope for RA fatigue - improvements seen in F sex, non-smokers, lack of depression, high baseline fatigue. Abst#1737 @RheumNow #ACR20. Interested in role of exercise in the study. Smoking is BIG cause of fatigue, must address with fatigued RA pts.
Eric Dein ejdein1 ( View Tweet)
Dr Winthrop reports on rates of influenza in RA in tofactinib clinical programme over 14-15 seasons. No significant differences in rates between tofa, ADA, MTX, and placebo. @rheumnow #ACR20 Abstr#L04 https://t.co/8RrG0I2Zwm
Richard Conway RichardPAConway ( View Tweet)
Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD consult) or appts. These observations show we were not prepared for this and that Rx suffered. #ACR20 Abstr#L05 https://t.co/vrDd0myGos https://t.co/JFUXItVdRQ
Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the annual #ACR20 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Deucravacitinib is a novel Tyrosine kinase 2 (TYK2) prev shown efficacy in psoriasis, now effective in PsA. PhII trial of 203 PsA patients showed wk 16 significant improvement in ACR20/50/70, enthesitis, SPARC scores. #ACR20 Abstr#L03 https://t.co/LGokmmlyrc
Dr. John Cush RheumNow ( View Tweet)
Intra-articulations steroids for the knee OA- finding benefits again! IA steroids were good then villified in press with accelerated cartilage loss. Pendulum swings back in abstr#1649 where quadriceps & gait improve post injection @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/0bRsiEKsW4
Janet Pope Janetbirdope ( View Tweet)
Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greater improvement in PROs with upadacitinib especially in physical functioning, pain, and general health @rheumnow #ACR20 Abstr#1728 https://t.co/NWKrhYAfZn
Richard Conway RichardPAConway ( View Tweet)
@wendycostello2 @psufka @RheumNow Here's the only abstract that I could find from #ACR20 regarding telemed in pedi rheum clinics. https://t.co/yun6QCv4fX It doesn't answer your question but it may be helpful to consider follow up with the authors.
Dr. Rachel Tate uptoTate ( View Tweet)
Evidence earlier in #ACR20 showed pts can give good reported jt scores. But PT globals, and evaluator globals, do not predict radiographic progression. MBDA does predict progression @LCalabreseDO @MeralElRamahiMD @RheumNow Abst#1730 https://t.co/YPWOqTRqV6
Eric Dein ejdein1 ( View Tweet)
Tocilizumab in GCA: what happens in the vessels?
Supporting excellent work @KQuinnRheum @petercgrayson earlier at #ACR20, LV-GCA data from Blanco/Gonzalez-Gay et al. Aorta still hot at 10.8±3.7 mo.
in LV-GCA on TCZ, clinical remission ≠ PET remission
#ACR20 ABST1921 @RheumNow https://t.co/ngBVL4rop8
David Liew drdavidliew ( View Tweet)
Will vagal nerve stimulation be clinically utilised? #ACR20 @rheumnow Abstr#1995
Richard Conway RichardPAConway ( View Tweet)
Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp
Dr. John Cush RheumNow ( View Tweet)
High #bloodpressure, jaw claudication and temporal artery abnormalities on palpation associated with increased risk of serious ischaemic events in #GCA, incl visual loss and #CVA. #MSK symptoms including PMR are protective.
Abs#1944 #ACR20 @RheumNow
https://t.co/sTeql8py9r
Mrinalini Dey DrMiniDey ( View Tweet)
@psufka @wendycostello2 @RheumNow I love seeing patients in person! However, being pregnant during COVID19 made me adjust my practice significantly (as we all did.) Watch https://t.co/99R5rPryui it helped me to visualize the PE in an entirely new way. @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Abs#1562 Detected subclinical synovitis/tenosynovitis in 37.2% of PsA pts in clinical remission. Do you routinely use MRI to monitor disease activity in your PsA patients? @RheumNow #ACR20
Robert B Chao, MD doctorRBC ( View Tweet)
SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA
Eric Dein ejdein1 ( View Tweet)
Very young rheum patients (<21 y.o) may have higher risk for preterm delivery compared to those 21-25 y.o
Abstr#1762 #ACR20 @rheumnow
https://t.co/NyLEan2sA1
k dao KDAO2011 ( View Tweet)